Dozens of women leaders such as Shaw and Reddy are spearheading Indian healthcare enterprises across segments such as ...

Syngene International appoints Peter Bains as MD & CEO. Syngene International announced that its board approved the appointment of Peter Bains as managing director (MD) and chief executive officer, ...

Syngene International Limited is an India-based integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health ...

Top Picks: Kotak Institutional Equities bets on Piramal Pharma, Syngene International, and Indegene; Here's everything you need to know (image Source: Freepik) The brokerage firm Kotak ...

Syngene International, operating in the Medical Research Services sector and classified as a Midcap on the BSE, currently has its share price at ₹701.3. The stock has experienced fluctuations ...

Raise the stop-loss to ₹520 when the price hits ₹560. Exit the longs at ₹620. The stock of Syngene International saw its price decline sharply between December 2024 and February 2025.

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods ...

A close look shows that Eugenie chose a sentimental shot for her lock screen Janine Henni is a Royals Staff Writer for PEOPLE Digital, covering modern monarchies and the world's most famous ...

I have a law review article entitled "Tinder Backgrounds" that is forthcoming in the Georgia Law Review (and whose draft is available here) trying to address this issue. Here is the abstract ...

Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/04/2024 inter alia to consider and approve the audited standalone and ...